ATE123148T1 - Verfahren zur erhöhung der testempfindlichkeit für mucin. - Google Patents

Verfahren zur erhöhung der testempfindlichkeit für mucin.

Info

Publication number
ATE123148T1
ATE123148T1 AT88309436T AT88309436T ATE123148T1 AT E123148 T1 ATE123148 T1 AT E123148T1 AT 88309436 T AT88309436 T AT 88309436T AT 88309436 T AT88309436 T AT 88309436T AT E123148 T1 ATE123148 T1 AT E123148T1
Authority
AT
Austria
Prior art keywords
mucin
test sensitivity
increase test
treatment
neuraminidase
Prior art date
Application number
AT88309436T
Other languages
English (en)
Inventor
Peter S Linsley
Vincent Ochs
Diane Horn
Joseph P Brown
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Application granted granted Critical
Publication of ATE123148T1 publication Critical patent/ATE123148T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Peptides Or Proteins (AREA)
AT88309436T 1987-10-09 1988-10-10 Verfahren zur erhöhung der testempfindlichkeit für mucin. ATE123148T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10704087A 1987-10-09 1987-10-09

Publications (1)

Publication Number Publication Date
ATE123148T1 true ATE123148T1 (de) 1995-06-15

Family

ID=22314537

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88309436T ATE123148T1 (de) 1987-10-09 1988-10-10 Verfahren zur erhöhung der testempfindlichkeit für mucin.

Country Status (7)

Country Link
US (1) US5646002A (de)
EP (1) EP0313244B1 (de)
JP (1) JP2779178B2 (de)
AT (1) ATE123148T1 (de)
CA (1) CA1340927C (de)
DE (1) DE3853866T2 (de)
ES (1) ES2073402T3 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3850046D1 (de) * 1987-11-20 1994-07-14 Abbott Lab Nachweis von Tumorassozierten Anzeigern in biologischen Flüssigkeiten.
AU656716B2 (en) * 1989-09-15 1995-02-16 Genetic Systems Corporation Hybridoma CT43 producing a monoclonal antibody to a mucin epitope of colorectal cancer
GB9304979D0 (en) * 1993-03-11 1993-04-28 Sinvent As Imobilisation and separation of cells and other particles
EP0937157A1 (de) * 1996-11-04 1999-08-25 Merck Frosst Canada & Co. Hydrolase bindungstest
US7407773B2 (en) * 2000-11-03 2008-08-05 Procognia, Ltd. Method for characterizing a carbohydrate polymer
EP2261255A1 (de) * 2003-07-15 2010-12-15 The Regents of The University of California Verfahren zur Reinigung von Sialinsäure-spezifischen Antikörpern und Zusammensetzung, die die affinitätsgereinigten Antikörper enthält
EP1709443A2 (de) * 2003-12-18 2006-10-11 Procognia, Ltd. Verfahren zur analyse eines glykomoleküls
JP5066615B2 (ja) * 2011-01-31 2012-11-07 株式会社日立製作所 フェニルボロン酸基と特異的に結合するオリゴペプチド配列
WO2013151649A1 (en) 2012-04-04 2013-10-10 Sialix Inc Glycan-interacting compounds
FI3218005T3 (fi) 2014-11-12 2023-03-31 Seagen Inc Glykaanin kanssa vuorovaikutteisia yhdisteitä ja käyttömenetelmiä
CA3002097A1 (en) 2015-11-12 2017-05-18 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
WO2018094143A1 (en) 2016-11-17 2018-05-24 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
WO2018160909A1 (en) 2017-03-03 2018-09-07 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4116776A (en) * 1976-04-19 1978-09-26 International Radioimmune Systems, Inc. Diagnostic blood test and kit for detecting human chorionic gonadotropin
US4146603A (en) * 1977-02-18 1979-03-27 Research Corporation Tumor specific glycoproteins and method for detecting tumorigenic cancers
US4762800A (en) * 1984-04-26 1988-08-09 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies to cell surface antigens of human teratocarcinomas
US4708930A (en) * 1984-11-09 1987-11-24 Coulter Corporation Monoclonal antibody to a human carcinoma tumor associated antigen
US4743543A (en) * 1985-09-09 1988-05-10 Coulter Corporation Method for enhancing and/or accelerating immunoassay detection of human carcinoma tumor associated antigen in a pathology sample
FR2590674B1 (fr) * 1985-11-25 1989-03-03 Inst Nat Sante Rech Med Nouveaux reactifs de diagnostic
DE3850046D1 (de) * 1987-11-20 1994-07-14 Abbott Lab Nachweis von Tumorassozierten Anzeigern in biologischen Flüssigkeiten.

Also Published As

Publication number Publication date
EP0313244B1 (de) 1995-05-24
EP0313244A3 (en) 1990-08-01
DE3853866D1 (de) 1995-06-29
ES2073402T3 (es) 1995-08-16
US5646002A (en) 1997-07-08
EP0313244A2 (de) 1989-04-26
JPH01237454A (ja) 1989-09-21
DE3853866T2 (de) 1995-09-21
JP2779178B2 (ja) 1998-07-23
CA1340927C (en) 2000-03-14

Similar Documents

Publication Publication Date Title
ATE123148T1 (de) Verfahren zur erhöhung der testempfindlichkeit für mucin.
LV10538A (lv) Imunologiski saistamas vielas noteiksanas panemiens biologiska skidruma un diagnostikas lidzeklis
DE3587172D1 (de) Verfahren zur identifizierung von liganden an ort und stelle.
DE3681396D1 (de) Verfahren zur raffinierung von kohlenhydraten und bei diesem verfahren verwendbare enzymmischungen.
ES8900067A1 (es) Un metodo y su correspondiente dispositivo para la determinacion de anticuerpos en liquidos biologicos.
DE69132238D1 (de) Verfahren zur Stabilisierung von Enzym-Konjugaten
ATE14631T1 (de) Verfahren und mittel zur immunologischen bestimmung von enzymen.
SE8304145D0 (sv) Antigenanalysmetod och set
ATA43187A (de) Verfahren zur quantitativen bestimmung von nucleinsaeure-molekuelen und reagenziensatz hierfuer
DE69012440D1 (de) Verfahren zur Bestimmung von Nukleinsäuren.
ATE67520T1 (de) Verfahren zur fotometrischen bestimmung der aktivierten partiellen thromboplastinzeit und reagenz dazu.
ATE36557T1 (de) Verfahren zur bestimmung der wirksamkeit von substraten oder enzymen.
ATA463976A (de) Verahren zur bestimmung von thrombin und thrombinartigen enzymen durch spaltung chromogene substrate
ATE42836T1 (de) Verfahren und reagenz zur quantitativen bestimmung von freiem thyroxin in plasma, serum oder vollblut.
DE3482845D1 (de) Verfahren zur inaktivierung von unvertraeglichkeitsreaktionen verursachenden substanzen.
DE3850346D1 (de) Verfahren zur Selbstdurchführung von Enzymkinetik.
FI841145A7 (fi) Menetelmä hemoglobiinipitoisuuden kvantitatiiviseksi määrittämiseksi biologisessa näytteessä.
DE3781008D1 (de) Verfahren zur messung von wasserstoffperoxid oder zur messung eines peroxidfreimachenden enzyms oder biochemischen substrats.
ATE14353T1 (de) Mittel zur immunologischen diagnose sowie verfahren zu seiner herstellung.
ATE24241T1 (de) Verfahren zur feststellung und bestimmung eines biologischen stoffes durch erythroadsorption.
ATE107031T1 (de) Verfahren zur bestimmung eines liganden.
SE8501441D0 (sv) Forfarande och anordning for kvalitativ och kvantitativ analys av antigener, antikroppar och/eller mikroorganismer
ATE30340T1 (de) Analytisches verfahren und mittel zur bestimmung der protease-hemmungsfaehigkeit von serum.
ATE63166T1 (de) Verfahren zur immunologischen bestimmung von aminen, monoklonale antikoerper und testsatz zur durchfuehrung des verfahrens.
DE59009676D1 (de) Verfahren zur Bestimmung von Antigenen und/oder Antikörpern in menschlichen Körperflüssigkeiten sowie Set zur Durchführung des Verfahrens.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties